Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011)

Rob de Knegt; Geert Bezemer; AR Gool; JPH Drenth; Bettina Hansen; CE Droogleever Fortuijn; CJ Weegink; Michiel Hengeveld; HLA Janssen

doi:10.1111/j.1365-2036.2012.05036.x

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011)

Rob de Knegt, Geert Bezemer, AR Gool, JPH Drenth, Bettina Hansen, CE Droogleever Fortuijn, CJ Weegink, Michiel Hengeveld, HLA Janssen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	864-864
Number of pages	1
Journal	Alimentary Pharmacology & Therapeutics
Volume	35
Issue number	7
DOIs	https://doi.org/10.1111/j.1365-2036.2012.05036.x
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1365-2036.2012.05036.x

Cite this

de Knegt, R., Bezemer, G., Gool, AR., Drenth, JPH., Hansen, B., Droogleever Fortuijn, CE., Weegink, CJ., Hengeveld, M., & Janssen, HLA. (2012). Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011). Alimentary Pharmacology & Therapeutics, 35(7), 864-864. https://doi.org/10.1111/j.1365-2036.2012.05036.x

@article{7fd3adbde5bf49e29dee36aa1a1a2078,

title = "Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011)",

author = "{de Knegt}, Rob and Geert Bezemer and AR Gool and JPH Drenth and Bettina Hansen and {Droogleever Fortuijn}, CE and CJ Weegink and Michiel Hengeveld and HLA Janssen",

year = "2012",

doi = "10.1111/j.1365-2036.2012.05036.x",

language = "Undefined/Unknown",

volume = "35",

pages = "864--864",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "7",

}

de Knegt, R, Bezemer, G, Gool, AR, Drenth, JPH, Hansen, B, Droogleever Fortuijn, CE, Weegink, CJ, Hengeveld, M & Janssen, HLA 2012, 'Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011)', Alimentary Pharmacology & Therapeutics, vol. 35, no. 7, pp. 864-864. https://doi.org/10.1111/j.1365-2036.2012.05036.x

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011). / de Knegt, Rob; Bezemer, Geert; Gool, AR et al.
In: Alimentary Pharmacology & Therapeutics, Vol. 35, No. 7, 2012, p. 864-864.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011)

AU - de Knegt, Rob

AU - Bezemer, Geert

AU - Gool, AR

AU - Drenth, JPH

AU - Hansen, Bettina

AU - Droogleever Fortuijn, CE

AU - Weegink, CJ

AU - Hengeveld, Michiel

AU - Janssen, HLA

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1365-2036.2012.05036.x

DO - 10.1111/j.1365-2036.2012.05036.x

M3 - Article

SN - 0269-2813

VL - 35

SP - 864

EP - 864

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 7

ER -

de Knegt R, Bezemer G, Gool AR, Drenth JPH, Hansen B, Droogleever Fortuijn CE et al. Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C (vol 34, pg 1306, 2011). Alimentary Pharmacology & Therapeutics. 2012;35(7):864-864. doi: 10.1111/j.1365-2036.2012.05036.x